lobbying_activities: 1738955

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1738955	93613ec1-795a-4338-967c-53334ee617ad	Q3	SLC HEALTH STRATEGIES, LLC	401018877	NOVO NORDISK PHARMACEUTICALS, INC.	2015	third_quarter	PHA	HR 6 - 21st Century Cures Act FDA issues regarding biosimilar products; 340B program matters	HOUSE OF REPRESENTATIVES,SENATE	22500		0	0	2015-10-19T13:45:27.897000-04:00